Fibrodysplasia ossificans progressiva: Case report;Postȩpuja̧ce kostnienie miȩśni: Opis przypadku

Polskie Archiwum Medycyny Wewnetrznej

Volumn 117, Issue 1-2, 2007, Pages 53-56

  Puszczewicz, Mariusz ^a   Kołczewska, Aleksandra ^a   Zimmermann Górska, Irena ^a   Majewski, Dominik ^a   Ogrodowicz, Agnieszka ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Calcinosis; Etidronate sodium; Fibrodysplasia ossificans progressiva

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HALLUX VALGUS; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSSIFICATION; OSSIFYING MYOSITIS; RADIOGRAPHY; CONDUCTION DEAFNESS; KINESIOTHERAPY; METHODOLOGY; MUSCLE; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADULT; EXERCISE THERAPY; FEMALE; HALLUX VALGUS; HEARING LOSS, CONDUCTIVE; HUMANS; MUSCLES; MYOSITIS OSSIFICANS; TREATMENT OUTCOME;

EID: 34249935641     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.77     Document Type: Article

References (11)

1. Szulc A. Postȩpuja̧ce kostnienie miȩśni: choroba Munchmeyera. W: Marciniak W, Szulc A, red. Ortopedia i rehabilitacja. Warszawa, WL PZWL, 2005: 193-194.
2. Pilch-Kowalczyk J, Klimek B, Konopka M, et al. Postȩpuja̧ce kostnieja̧ce zapalenie miȩśni - opis przypadku. Wiad Lek. 2003; 5-6: 293-297.
3. Semonin O, Fontaine K, Daviaud C, et al. Identification of three novel mutations of the noggin gene in patients with fibrodysplasia ossificans progressiva. Am J Med Genet. 2001; 102: 314-317.
4. Mahboubi S, Glaser DL, Shore EM, et al. Fibrodysplasia ossificans progressiva. Pediatr Radiol. 2001; 31: 307-314.
5. Whyte MP. Fibrodysplasia (myositis) ossificans progressiva. In: Murray JF, eds. Primer on the metabolic bone diseases and disorders of mineral metabolism. 2-nd ed. New York, Raven Press Ltd., 1993: 393-395.
6. Smith R, Athanasou NA, Vipond SE. Fibrodysplasia (myositis) ossificans progressiva: clinicopathological features and natural history. QJM. 1996; 89: 445-446.
7. Goldman AB. Heritable diseases of connective tissue, epiphysal dysplasia, and related conditions. In: Resnick D, eds. Diagnosis of bone and joint disorders. Philadelphia, WB Saunders, 2002: 4409-4415.
8. Shafritz AB, Shore EM, Gannon FH, et al. Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressive. N Engl J Med. 1996; 335: 555-561.
9. Levy CE, Lash AT, Janoff HB, et al. Conductive hearing loss in individuals with fibrodysplasia ossificans progressiva. Am J Audiol. 1999; 8: 29-33.
10. Brantus JF, Meunier PJ. Effects of intravenous etidronate and oral corticosteroids in fibrodysplasia ossificans progressiva. Clin Orthop. 1998; 346: 117-120.
11. Glaser DL, Kaplan FS. Treatment considerations for the management of fibrodysplasia ossificans progressiva. Clinical Reviews in Bone Mineral Metabolism 2005; 3: 243-250.